Thursday, July 9, 2026

pharma · Microcystic Lymphatic Malformation · Pachyonychia Congenita · PVLA

PALVELLA THERAPEUTICS

PALVELLA THERAPEUTICS trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Wayne, USA HQ
2015 Founded
38 Employees
Public company Type
PVLA · NYSE Ticker
Company details
Status
Public
HQ
Wayne, USA
Founded
2015
Employees
38
Programs
7
Drugs
0
Patents
9
Intelligence · Clinical Trials

PALVELLA THERAPEUTICS clinical trials

Registry index of 9 ClinicalTrials.gov studies linked to PALVELLA THERAPEUTICS programs — each row shows trial ID, program name, phase, status, and indication.

PALVELLA THERAPEUTICS trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

7 updates

Latest clinical program signals indexed for PALVELLA THERAPEUTICS.

  1. PTX-022 — Phase 3

    Clinical update
  2. QTORIN 3.9% Rapamycin Anhydrous Gel — Phase 3

    Clinical update
  3. QTORIN 3.9% rapamycin anhydrous gel — Phase 3

    Clinical update
  4. PTX-022 — Phase 2

    Clinical update
  5. PTX-022 — Phase 2

    Clinical update
  6. PTX-022 — Phase 2

    Clinical update
  7. QTORIN 3.9% rapamycin anhydrous gel — Phase 2

    Clinical update

Trial registry

9 studies